SARS-CoV-2 infection prevalence on repatriation flights from Wuhan City, China.

Thompson HA., Imai N., Dighe A., Ainslie KEC., Baguelin M., Bhatia S., Bhatt S., Boonyasiri A., Boyd O., Brazeau NF., Cattarino L., Cooper LV., Coupland H., Cucunuba Z., Cuomo-Dannenburg G., Djaafara B., Dorigatti I., van Elsland S., FitzJohn R., Fu H., Gaythorpe KAM., Green W., Hallett T., Hamlet A., Haw D., Hayes S., Hinsley W., Jeffrey B., Knock E., Laydon DJ., Lees J., Mangal TD., Mellan T., Mishra S., Mousa A., Nedjati-Gilani G., Nouvellet P., Okell L., Parag KV., Ragonnet-Cronin M., Riley S., Unwin HJT., Verity R., Vollmer M., Volz E., Walker PGT., Walters C., Wang H., Wang Y., Watson OJ., Whittaker C., Whittles LK., Winskill P., Xi X., Donnelly CA., Ferguson NM.

DOI

10.1093/jtm/taaa135

Type

Journal article

Journal

Journal of travel medicine

Publication Date

12/2020

Volume

27

Addresses

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.

Keywords

Humans, Prevalence, Epidemiologic Measurements, Communicable Disease Control, China, Travel Medicine, Epidemiological Monitoring, Air Travel, United Kingdom, International Health Regulations, COVID-19, SARS-CoV-2, COVID-19 Nucleic Acid Testing

Permalink Original publication